TREATMENT OF MUSCULAR DYSTROPHY.
D045930:Anabolic Agents; D035843:Biomedical Research; D006801:Humans; D008696:Methandrostenolone; D009136:Muscular Dystrophies; D009277:Nandrolone; D009639:Norethandrolone; D009705:Nucleosides; D009711:Nucleotides; D010600:Pharmacology; D013256:Steroids; D014116:Toxicology
D045930:Anabolic Agents; D009705:Nucleosides; D009711:Nucleotides; D013256:Steroids; D009277:Nandrolone; D008696:Methandrostenolone; D009639:Norethandrolone
ANABOLIC STEROIDS; CLINICAL RESEARCH; METHANDROSTENOLONE; MUSCULAR DYSTROPHY; NANDROLONE; NORETHANDROLONE; NUCLEOSIDES; NUCLEOTIDES; PHARMACOLOGY; TOXICOLOGIC REPORT